3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Ovarian High Grade Serous Adenocarcinoma
1
Medulloblastoma
1
Locally Advanced Non-Small Cell Lung Cancer
1
Leukemia, Myeloid, Acute
1
Hypoxia
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Temozolomide
10
Radiotherapy
10
Bevacizumab
6
Everolimus
5
ribociclib
3
Radiation
3
Panobinostat
3
Dasatinib
3
Valproic Acid
2
TIC10 compound
2
Re-Irradiation
2
Nivolumab
2
Mebendazole
2
Irinotecan
2
Gemcitabine
2
GDC-0084
2
Etoposide
2
Erlotinib Hydrochloride
2
Diphtheria-Tetanus Vaccine
2
Cyclophosphamide
2
Cilengitide
2
Cetuximab
2
vandetanib
1
tovorafenib
1
temsirolimus
1
spartalizumab
1
sargramostim
1
reolysin
1
pembrolizumab
1
ovex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Diffuse Intrinsic Pontine Glioma
×
Atovaquone
×
Clear all
NCT06624371
2025-07-22
AflacBT2303
Emory University
Phase 1
Recruiting
18 enrolled